1. Home
  2. NKTR vs HUN Comparison

NKTR vs HUN Comparison

Compare NKTR & HUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$71.44

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo Huntsman Corporation

HUN

Huntsman Corporation

HOLD

Current Price

$11.94

Market Cap

2.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NKTR
HUN
Founded
1990
1970
Country
United States
United States
Employees
N/A
6000
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.1B
IPO Year
1996
2004

Fundamental Metrics

Financial Performance
Metric
NKTR
HUN
Price
$71.44
$11.94
Analyst Decision
Strong Buy
Hold
Analyst Count
7
11
Target Price
$146.67
$12.09
AVG Volume (30 Days)
833.2K
3.9M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
2.64%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$307,711,000.00
$5,683,000,000.00
Revenue This Year
N/A
$3.08
Revenue Next Year
N/A
$5.27
P/E Ratio
N/A
N/A
Revenue Growth
86.00
N/A
52 Week Low
$21.02
$7.30
52 Week High
$109.00
$16.09

Technical Indicators

Market Signals
Indicator
NKTR
HUN
Relative Strength Index (RSI) 54.99 47.93
Support Level $64.28 $10.45
Resistance Level $76.78 $12.41
Average True Range (ATR) 3.57 0.56
MACD 0.17 0.09
Stochastic Oscillator 66.12 43.53

Price Performance

Historical Comparison
NKTR
HUN

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

About HUN Huntsman Corporation

Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. The product portfolio of the company comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, and others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. The company derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.

Share on Social Networks: